Figure 4.
AC improves AD-like behaviors in d-gal and AlCl3 development AD mice. Compared with non-treated AD mice, 28-day AC administration enhanced horizontal movements(A) and vertical movements (B) in locomotor activity test; (C) enhanced the remaining time in rotating test; (D) reduced the escape latency time in WMT. Data expressed as mean ± S.E.M. (n = 12). # p < 0.05 and ## p < 0.01 vs. control mice, * p < 0.05 and ** p < 0.01 vs. AD mice.